Skip to main content

Table 1 Dosing scheme utilized in the adult and juvenile target animal safety studies

From: Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) in juvenile and adult dogs

Dose level

Dose administration study days

0, 28, 56, 84, 112, 140, 168, 196*, 224*

1, 29, 57, 85, 113, 141, 169, 197*, 225*

2, 30, 58, 86, 114, 142, 170, 198*, 226*

3, 31, 59, 87, 115, 143, 171, 199*, 227*

4, 32, 60, 88, 116, 144, 172, 200*, 228*

0X

Placebo

Placebo

Placebo

Placebo

Placebo

1X

Placebo

Placebo

Placebo

Placebo

1X

3X

Placebo

Placebo

1X

1X

1X

5X

1X

1X

1X

1X

1X

  1. * Juvenile study only